Multicenter ACL Revision Study (MARS)
Study Details
Study Description
Brief Summary
The purpose of this study is to determine the effects of modifiable risk factors on patient-reported quality of life, physical activity levels, and risk of early osteoarthritis following revision anterior cruciate ligament (ACL) reconstruction.
The investigators hypothesize that modifiable variables exist at the time of revision ACL reconstruction (e.g., cause of failure, current graft source and type, surgical exposure, and femoral and tibial tunnel position) which will be predictors of patient-reported outcomes.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Injury to the anterior cruciate ligament (ACL) results in a threat to an active lifestyle and exposes the patient to risk of osteoarthritis. ACL reconstruction is typically chosen by individuals to allow a return to their previous work and sports activities. The results of primary ACL reconstruction have in general been good at restoring functional stability. Primary ACL reconstruction has a graft failure rate ranging from approximately 2%-8%. Consensus amongst surgeons and low-level evidence (retrospective case series) indicate a worse outcome following revision ACL reconstruction compared to primary reconstruction. The typical surgeon performs less than 10 revision ACL reconstructions per year. Thus, the ability of any single surgeon or small group of surgeons to accumulate enough cases to effectively analyze predictors for worse outcome is impossible.
With this in mind, the Multi-Center ACL Revision Study (MARS) group was established as a multi-center surgeon group to perform a prospective longitudinal cohort analysis of revision ACL reconstruction. This is a mixed group of academic and private practice physicians and has been supported and endorsed by the American Orthopedic Society for Sports Medicine (AOSSM).
This study focuses on the predictors for ACL revision outcome at 2, 6, and 10 years following a patient's revision ACL reconstruction. This will be accomplished by three Specific Aims. Specific Aim 1 will determine the independent predictors of patient-reported quality of life, utilizing a general (SF-36) and knee-specific (Knee Injury and Osteoarthritis Outcome Score - KOOS) validated outcome instrument. Specific Aim 2 will determine the independent predictors of sports function utilizing three validated outcome instruments (the Marx activity level, International Knee Documentation Committee Subjective form - IKDC, and the KOOS sports and recreation subscale). Specific Aim 3 will identify those independent modifiable predictors measured at the time of the revision ACL reconstruction associated with symptoms of early osteoarthritis at 2, 6, and 10 years post-surgery. Symptoms will be quantified using the validated survey instrument the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Once the predictors for these worse outcomes are identified, surgeons can be educated in potential modifiable variables to improve the outcome.
Study Design
Outcome Measures
Primary Outcome Measures
- Graft re-rupture [2, 6, and 10 years after revision ACL surgery]
Secondary Outcome Measures
- Patient based outcome measures [2, 6, and 10 years after revision ACL surgery]
Activity level (as measured by the Marx activity scale). Sports function (as measured by the KOOS and IKDC). Pain and swelling (as measured by the WOMAC).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All ACL-deficient candidates presenting to the clinic, between the ages of 12† and 65, scheduled to have a revision ACL reconstruction by a participating (MARS Study) surgeon.
-
All participants must have undergone a primary ACL reconstruction in the past and are currently identified as having experienced failure of their primary ACL reconstruction, as defined by either MRI, knee laxity (KT > 5mm), a positive pivot shift or Lachman's, functional instability, and/or by arthroscopic confirmation.
-
All ACL-deficient patients seeking a revision ACL reconstruction that have either partial (Grade I or II) and/or complete (Grade III) simultaneous ligamentous injuries to the collateral ligaments (MCL or LCL) and/or the posterior cruciate ligament (PCL) will also be included.
-
Non-operative treatment of patients with ACLR failure are also eligible to participate.
-
The following graft types will be the only ones accepted for inclusion:
-
any autograft
-
Fresh-frozen allografts from a single donor source (Musculoskeletal Transplant
Foundation (MTF); Edison, NJ). These grafts should consist of either:
-
bone-patellar tendon-bone
-
tibialis anterior/posterior
-
achilles tendon
Exclusion Criteria:
-
Patients presenting with prior infection, arthrofibrosis, or regional pain syndrome.
-
Subjects will be excluded if their allograft source does not come from MTF.
-
Patients unwilling or unable to complete their repeat questionnaire two years after their initial visit.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Scripps Memorial Hospital (OrthoCal Healthcare) | La Jolla | California | United States | 92123 |
2 | University of California - Los Angeles (UCLA) | Los Angeles | California | United States | 90095 |
3 | University of California - San Francisco | San Francisco | California | United States | 94143 |
4 | Orthopaedic Associates of Aspen and Glenwood | Aspen | Colorado | United States | 81611 |
5 | University of Colorado | Boulder | Colorado | United States | 80304 |
6 | Connecticut Children's Medical Center | Farmington | Connecticut | United States | 06032 |
7 | University of Connecticut Health Center | Farmington | Connecticut | United States | 06034 |
8 | UHZ Sports Medicine Institute | Coral Gables | Florida | United States | 33146 |
9 | Intermountain Orthopaedics | Boise | Idaho | United States | 83703 |
10 | Rush University Medical Center | Chicago | Illinois | United States | 60612 |
11 | Methodist Sports Medicine Center | Indianapolis | Indiana | United States | 46280 |
12 | University of Iowa | Iowa City | Iowa | United States | 52242 |
13 | Cheaspeake Orthopaedics and Sports Medicine Center | Glen Burnie | Maryland | United States | 21061 |
14 | Beth Israel Deaconess Medical Center | Boston | Massachusetts | United States | 02215 |
15 | University of Michigan | Ann Arbor | Michigan | United States | 48106 |
16 | Mayo Clinic | Rochester | Minnesota | United States | 55905 |
17 | Regions Hospital (Health Partners Research Foundation) | Saint Paul | Minnesota | United States | 55101 |
18 | Washington University at St. Louis | Saint Louis | Missouri | United States | 63141 |
19 | Bridger Orthopaedic and Sports Medicine | Bozeman | Montana | United States | 59715 |
20 | New Hamphsire Knee Center | Holderness | New Hampshire | United States | 03217 |
21 | Robert Wood Johnson Medical School | New Brunswick | New Jersey | United States | 08901 |
22 | Princeton Orthopaedic Associates | Princeton | New Jersey | United States | 08540 |
23 | University of Buffalo | Buffalo | New York | United States | 14214 |
24 | NYU School of Medicine | New York | New York | United States | 10016 |
25 | Hospital for Special Surgery | New York | New York | United States | 10021 |
26 | Manhattan Orthopaedics, P.C. | New York | New York | United States | 10021 |
27 | Keller Army Community Hospital - USMA | West Point | New York | United States | 10996 |
28 | University of North Carolina Medical Center | Chapel Hill | North Carolina | United States | 27599 |
29 | Perry Orthopaedics and Sports Med (Carolinas Healthcare System) | Charlotte | North Carolina | United States | 28211 |
30 | Duke University | Durham | North Carolina | United States | 27710 |
31 | Cleveland Clinic | Cleveland | Ohio | United States | 44195 |
32 | The Ohio State University | Columbus | Ohio | United States | 43221 |
33 | Slocum Research and Education Foundation | Eugene | Oregon | United States | 97401 |
34 | Orthopaedic and Fracture Clinic | Portland | Oregon | United States | 97225 |
35 | The Rothman Institute / Thomas Jefferson University | Philadelphia | Pennsylvania | United States | 19085 |
36 | University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104 |
37 | Booth, Bartolozzi, Balderston Orthopaedics | Philadelphia | Pennsylvania | United States | 19107 |
38 | Orthopaedic Institute | Sioux Falls | South Dakota | United States | 57115 |
39 | Southeastern Orthopaedics / Knoxville Orthopaedic Clinic | Knoxville | Tennessee | United States | 37909 |
40 | Vanderbilt University | Nashville | Tennessee | United States | 37232 |
41 | W.B. Carroll Memorial Clinic | Dallas | Texas | United States | 75204 |
42 | San Antonio Orthopaedic Group | San Antonio | Texas | United States | 78216 |
43 | University of Vermont College of Medicine | Burlington | Vermont | United States | 05405 |
44 | National Sports Medicine Institute | Lansdowne Town Center | Virginia | United States | 20176 |
45 | Town Center Orthopaedic Associates | Reston | Virginia | United States | 20190 |
46 | Commonwealth Orthopaedics and Rehabilitation | Vienna | Virginia | United States | 22181 |
47 | Inland Orthopaedics/Washington State University | Pullman | Washington | United States | 99163 |
48 | Royal Columbian Hospital (FraserHealth) | New Westminster | British Columbia | Canada | V3L3W7 |
49 | Fowler Kennedy Sports Medicine Clinic/Univ. of Western Ontario | London | Ontario | Canada |
Sponsors and Collaborators
- Vanderbilt University
- Vanderbilt University Medical Center
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Investigators
- Principal Investigator: Rick W. Wright, M.D., Vanderbilt University Medical Center
- Principal Investigator: Kurt P. Spindler, M.D., Vanderbilt University Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 070110
- R01AR060846